| Molecular formula | C149H225N39O46 |
|---|
| Molecular weight | 3298.6 g/mol |
|---|
| Registered trials | 3 |
|---|
| PubChem CID | 16209124 |
|---|
What Beinaglutide Is
Beinaglutide is a peptide compound (PubChem CID 16209124) with a molecular formula of C149H225N39O46. It does not have an FDA-approved label, and no approved indications, dosing, or safety information have been established through that process. Any use outside of registered clinical research falls outside current regulatory oversight.
Clinical Trial Footprint
Beinaglutide has been studied in 3 registered clinical trials. The available sample includes a completed trial comparing beinaglutide to glargine therapy for glycemic variability in type 2 diabetes mellitus, and a recruiting trial comparing continuous subcutaneous beinaglutide delivery to insulin pump therapy in newly diagnosed type 2 diabetes patients. A third trial compares beinaglutide and dulaglutide for glucose control and weight loss in people with type 2 diabetes who are overweight or obese, though its current status is unknown. These registrations indicate an area of active research interest but do not establish safety or effectiveness for any use.
FAQ
No. Beinaglutide does not have an FDA-approved label, and there is no approved indication, dosing, or safety information on file with the agency. It remains an investigational compound studied only in the context of registered clinical research.
Registered trials involving beinaglutide have focused on type 2 diabetes, including comparisons to other glucose-lowering therapies like glargine and dulaglutide. This reflects the direction of current research interest rather than any established or approved use.
There are 3 registered clinical trials involving beinaglutide. These include completed, recruiting, and status-unknown studies conducted in type 2 diabetes populations.
No structured adverse event reporting data is currently available for beinaglutide in this review. Any safety profile would need to come from the completed clinical trials themselves rather than from post-market surveillance, since no approved product exists.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 16209124 ClinicalTrials.gov
Updated 2026-11-07